Thierry Dervieux
9PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Apr 08, 2026
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn's Disease.Wei Zhang, Zhigang Wang, Thierry Dervieux
|Apr 05, 2024
Simulated cost-effectiveness of a novel precision-guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy.Elmar R Alizadeh, Thierry Dervieux, Severine Vermeire
|Aug 18, 2023
Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically.Emily K Wright, Maria Chaparro, Paolo Gionchetti
|Feb 09, 2023
Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE).John Conklin, Michael Golpanian, Alexis Engel
|May 07, 2020
Cell-bound complement activation products associate with lupus severity in SLE.Cristina Arriens, Roberta Vezza Alexander, Sonali Narain
|Oct 09, 2019
Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE.Daniel J Wallace, Roberta Vezza Alexander, Tyler O'Malley
Pageof 2
Frequent Collaborators
3 joint publications
Roberta Vezza Alexander
2 joint publications
Tyler O'Malley
1 joint publications
Michael Mahler
1 joint publications
Chelsea Bentow
1 joint publications
Cristina Arriens
1 joint publications
Chaim Putterman
1 joint publications
Jill P Buyon
1 joint publications
Maria Chaparro
1 joint publications
Amy L Hamilton
1 joint publications
Javier P Gisbert
